Conversely, CCR4 overexpression in CCR4overexpress mice at 72 h post‐ICH resulted in significantly reduced hematoma volume and improved neurological outcomes compared to sham controls (Figure 3A–C). This evidence concerns the gene CCR4 and hematoma.